Pharma Journalist -

PharmaTher Holdings Ltd. announced that the U.S. Food and Drug Administration (“FDA”) has granted orphan drug designation to KETARX (racemic ketamine) for the treatment of Rett…
Read More...

Purple Biotech Ltd. announced that it has entered into an agreement for the acquisition of Immunorizon Ltd., a private company developing potential multi-specific T and NK cell engager…
Read More...

Tonix Pharmaceuticals Holding Corp. announced an agreement whereby Tonix has acquired all of the assets of Healion Bio, Inc. (Healion) including its entire portfolio of next-generation…
Read More...

Karuna Therapeutics, Inc. and GFB (ABC), LLC, assignee of the Goldfinch Bio assignment estate, announced their entry into an exclusive license agreement under which Karuna will obtain…
Read More...

4D Molecular Therapeutics, a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, announced FDA clearance of the…
Read More...

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model,…
Read More...

GSK plc announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the…
Read More...

The University of Texas MD Anderson Cancer Center and Federation Bio, a biotechnology company pioneering bacterial cell therapies, announced a strategic collaboration to design and…
Read More...

Cidara Therapeutics, Inc. and WuXi XDC announced an expansion of their existing collaboration under which WuXi XDC will provide investigational new drug (IND)-enabling chemistry,…
Read More...

GSK plc announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Benlysta (belimumab), a B-cell inhibiting monoclonal antibody, for the…
Read More...